Genome Sweet Genome


© John McManamy

"Researchers will be able to analyze groups of genes working together, looking at how they might be altered in manic depression or other disorders."

The following article is based on two pieces that appeared in my newsletter:

Last month's announcement that the human genome had been mapped out well ahead of schedule merited the full lunar landing treatment. Nevertheless, at least one commentator reminded us that we haven't been back on the moon in more than 30 years, much less put it to practical use. An historic breakthrough yes, but we are talking in terms of decades before we start reaping the real benefits of our genomic knowledge.

A series of articles in the New York Times offers an excellent perspective on where we are and how far we have yet to go:

According to Dr Francis Collins, head of the Human Genome Project of the NIH, by the year 2010 genetic tests will help identify people at highest risk of particular diseases. By 2020, doctors will rely on individual genetic variations in prescribing drugs, and by 2030, clinical trials based on genomic information will be underway to extend the human lifespan. Thanks to our advanced knowledge, many experiments done on lab animals or humans can be completed on computers. By 2040, gene therapy and gene-based drugs will be available for most diseases, and the average life span will be 90 (the year I turn 91, to bring this down to a personal level).

One research scientist told this writer that Dr Collins may be painting an overly rosy picture in order to keep the funds flowing in. That may well be the case, but one should never discount the possibility of the unforeseen breakthrough, either.

Genes are responsible for making proteins, which are the working parts of human cells, serving a variety of purposes from acting as cellular ceiling joists to catalyzing chemical reactions. In the words of the NY Times: "Understanding the role of every human protein - proteomics - will be one of the goals of the post-genome era."

But don't expect a Eureka! being cried out in some dark lab late at night over the discovery of a depression or bipolar gene. In all likelihood, mental illness stems not from a single gene, but from multiple genes acting with one another as well as the environment.

Perhaps some of you recall the announcement made in 1987 by a group of scientists who were convinced they had found the bipolar gene. After an investigation of Amish families, they thought they had pinpointed the culprit near the tip of the short arm of chromosome 11, only to concede

Go To Page: 1 2 3


The copyright of the article Genome Sweet Genome in Depression is owned by John McManamy. Permission to republish Genome Sweet Genome in print or online must be granted by the author in writing.

Post this Article to facebook Add this Article to del.icio.us! Digg this Article furl this Article Add this Article to Reddit Add this Article to Technorati Add this Article to Newsvine Add this Article to Windows Live Add this Article to Yahoo Add this Article to StumbleUpon Add this Article to BlinkLists Add this Article to Spurl Add this Article to Google Add this Article to Ask Add this Article to Squidoo


Here's the follow-up discussion on this article: View all related messages

2.   Jul 29, 2000 9:04 AM
This one's definitely a roulette game. There's simply not enough money to support the follow-up research to all the breakthroughs that are happening, much less develop various products and bring them ...

-- posted by mcman


1.   Jul 27, 2000 8:36 PM
and the right team of folks make the decision to use the new knowledge. Politics have turned lots of astounding finds into games where money and big industry rule. If a drug company finds it may inf ...

-- posted by jerrib





For a complete listing of article comments, questions, and other discussions related to John McManamy's Depression topic, please visit the Discussions page.